Medescreen

10x Genomics, based in Cambridge, MA, specializes in innovative genomic technologies that enhance research capabilities in single-cell and spatial multiomics. Their products, including the Chromium Single Cell platform and Visium Spatial platform, enable researchers to conduct high-quality, large-scale studies at more affordable price points. With a commitment to advancing scientific understanding, 10x Genomics empowers scientists to explore cellular diversity, detect novel biomarkers, and analyze gene expression patterns. The company has contributed to over 8,200 publications, showcasing the impact of their technology on the life sciences community. Generated from the website

Exosome Diagnostics is a biotechnology company based in Cambridge, MA, specializing in the development of non-invasive liquid biopsy tests. Utilizing exosome technology, the company focuses on providing innovative solutions for the early detection and monitoring of various diseases. Generated from their business information

Bluebird Bio, based in Cambridge, MA, is a pioneering company focused on developing curative gene therapies for patients and their families. With a decade of experience in gene therapy, they are setting the standard in the field and have the largest ex vivo gene therapy data set in the world. Their one-time gene therapy treatments, designed to deliver functional copies of genes to patients' cells, aim to provide more "bluebird days" for those affected by diseases such as beta thalassemia, cerebral adrenoleukodystrophy, and sickle cell disease. Bluebird Bio is dedicated to advancing the field of gene therapy through collaboration, diversity, equity, and inclusion, ensuring that patient advocacy and well-being remain at the forefront of their mission. Generated from the website